Mollie Leoni - Jan 28, 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Medical Officer
Signature
Teresa Bair, Attorney-in-fact for Mollie Leoni
Stock symbol
KURA
Transactions as of
Jan 28, 2025
Transactions value $
-$39,068
Form type
4
Date filed
1/28/2025, 08:39 PM
Previous filing
Jan 7, 2025
Next filing
Sep 29, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$17.7K -2.25K -2.42% $7.87 91K Jan 28, 2025 Direct F1
transaction KURA Common Stock Sale -$10.7K -1.35K -1.49% $7.87 89.6K Jan 28, 2025 Direct F2
transaction KURA Common Stock Sale -$6.42K -816 -0.91% $7.87 88.8K Jan 28, 2025 Direct F3
transaction KURA Common Stock Sale -$4.26K -541 -0.61% $7.87 88.3K Jan 28, 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
F2 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
F3 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
F4 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.